Currently there is no vaccine to prevent this virus and no specific antiviral therapy to treat HMPV, according to the CDC.

Therapists role is changing. Thus, a new business model of therapy and payment needs to be devised. Idea: subscription model. An AI Insider scoop.

The update offers an important new starting point, but it should not be an endpoint ...

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2025 Earnings Call Transcript March 5, 2026 REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $-1.01. Operator: Thank you for ...

Founder, who will provide a business update and an overview of our clinical and operational progress. Rita Johnson Green, our ...

Learn about peripheral artery disease and its effects on blood flow. We explain symptoms, risk factors, and treatments to ...

Raw milk may soon be legal to sell in larger quantities by farmers, but the latest edits to the bill state the product cannot ...

Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today reported financial results for fourth quarter and full year 2025 and provided ...

4D Molecular Therapeutics, Inc. ( FDMT) TD Cowen 46th Annual Health Care Conference March 3, 2026 10:30 AM EST ...

Financing Expected to Fund Completion of Phase 2 Ovarian Cancer TrialFinancing Supports Acceleration Toward Pivotal Trial and CommercializationFinancing Structured as Non-Convertible Debt Financing ...

As its waiting list grows, the Salvation Army believes the SoMa shelter's popularity could indicate demand for other sober housing alternatives.

Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered ...